Clinical Trial

The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During Spinal Anesthesia

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The cutaneous silent period is a non-invasive technique that gives insight into the function of thin A delta fibers and as such can be a complement to conventional electrophysiological methods used to study the peripheral nerves. Clonidine is a selective partial agonist of the alpha-2 receptors which, added intrathecally to levobupivacaine, enhances the effect of a local anesthetic, prolongs sensory and motor block during local anesthesia and extends the length of post-operative analgesia. It is believed that clonidine achieves this effect by activating the postsynaptic alpha-2 receptors in the gelatine substance of the spinal cord and blocking the conduction of A-delta and C fibers. The aim of the study is to examine functional changes of Aδ - fibers during the application of spinal anesthesia by measuring the cutaneous slinet period and compare the effect of intrathecal administration of a combination of local anesthetic and clonidine in the quiet skin period in relation to the application of local anesthetic only.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2017-04-19; most recent amendment 2026-04-28.
Trial Details
NCT Number NCT03121261
Lead Sponsor University Hospital Dubrava
Conditions Inguinal Hernia, Spinal Anesthesia
Enrollment 60 participants
Start Date 2017-05-01
Primary Completion 2027-09 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-04